The RGAG4 protein is a pivotal component in specific cellular pathways, and its activity can be modulated by various biochemical activators. These activators function through distinct mechanisms that ultimately lead to the increased activity of RGAG4. For instance, certain activators target adenylyl cyclase, directly stimulating it to elevate intracellular cAMP levels. This second messenger plays a critical role in cAMP-dependent pathways, which are known to interact with proteins such as RGAG4, thereby enhancing its cellular function. Similarly, the use of cAMP analogs serves to mimic this effect, providing a sustained activation of these pathways and indirectly promoting the functional activity of RGAG4. Other activators work by increasing intracellular calcium concentrations, either through direct ionophoretic mechanisms or by agonizing calcium channels, which then activate calcium-dependent proteins that can influence the activity of RGAG4.
Beyond the modulation of second messengers, there are activators that affect RGAG4 through alterations in protein phosphorylation. Specific compounds can activate protein kinase C, which has the potential to phosphorylate a range of substrates that interact with RGAG4, thereby influencing its activity. In a similar vein, the inhibition of phosphodiesterases leads to an accumulation of cAMP, which indirectly could result in the enhanced activity of RGAG4. On a different aspect of cellular regulation, some activators disrupt the structural integrity of the Golgi apparatus, influencing intracellular trafficking and signaling pathways that may indirectly affect RGAG4 activity. Additionally, the inhibition of protein phosphatases results in an increased phosphorylation state of various proteins, which could subsequently lead to the activation of RGAG4 through altered signaling dynamics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Directly stimulates adenylyl cyclase, increasing intracellular cAMP levels which could enhance the activity of RGAG4 through cAMP-dependent pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC), which may phosphorylate substrates that could interact with RGAG4, thus potentially increasing its activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
A beta-adrenergic agonist that increases cAMP levels, potentially enhancing the activity of RGAG4 via cAMP-mediated signaling cascades. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium concentration, which could activate calcium-dependent proteins that modulate the function of RGAG4. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A calcium ionophore that raises intracellular calcium levels, possibly promoting the activation of RGAG4 through calcium signaling pathways. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
A cAMP analog that activates cAMP-dependent pathways, potentially leading to an increase in RGAG4 activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
A cAMP analog which may activate cAMP-dependent protein kinases that could indirectly increase the activity of RGAG4. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
A hormone and neurotransmitter that can increase cAMP levels through its interaction with adrenergic receptors, possibly enhancing RGAG4 activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
A nonspecific inhibitor of phosphodiesterases that prevents cAMP degradation, possibly leading to increased activity of RGAG4 via elevated cAMP. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $82.00 $192.00 $801.00 | ||
A calcium channel agonist that could increase intracellular calcium and indirectly activate RGAG4 through calcium-dependent signaling mechanisms. |